The BIOXHIT project:
BIOXHIT stands for
Biocrystallography (X) on a Highly Integrated Technology Platform for
European Structural Genomics and is funded under the 6th Framework
Programme of the European Commission (LSHG-CT-2003-503420).
BIOXHIT was a unique
project in the field of structural genomics and was funded for 4.5 years
(from January 2004 to June 2008) with a total budget sum of about 10
million Euros.
The ability of
post-genomic research in biology and medicine to deliver substantial
improvements in human health depends critically on the rate of progress towards
the understanding of complex biological processes at the molecular level. This
in turn depends on processes to rapidly determine the 3D structures of all
biological molecules in atomic detail. Biological crystallography aims to
create precise, three-dimensional "architectural" models of biological
molecules. Without such models, it is nearly impossible to understand
biological processes: for instance the way that proteins and other molecules behave
in cells, or to design new drugs that will affect their function.
BIOXHIT mobilized on the one hand
all European synchrotron facilities with beamlines equipped for macromolecular
crystallography - either already in existence or planned for the future; and on
the other hand most of the software developers active in fields relevant to
high-throughput structure determination. This represented the greatest possible
organization of resources at the European level, both in terms of infrastructure
and scientific talents.
View the BIOXHIT slideshow.
|